Patents Assigned to Foundation
  • Patent number: 8155730
    Abstract: The present invention provides a method of optical electrophysiological probing, including: providing a fluorescing chemical probe; contacting a thick portion of tissue with the fluorescing chemical probe to create a thick portion of treated tissue; applying a first range of wavelengths of electromagnetic radiation to the treated portion of tissue; and detecting a plurality of depth-specific emission wavelengths emitted from the thick portion of treated tissue.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: April 10, 2012
    Assignee: The Research Foundation of State University of New York
    Inventors: Arkady M. Pertsov, Arvydas Matiukas, Leslie M. Loew, Joseph P. Wuskell
  • Patent number: 8153827
    Abstract: The present disclosure provides isotopically substituted compounds of the formula (I): wherein T, U, V, W, X, Y, Z, R0, R3, R4, R5 and R6 are as defined in the detailed description. The method for detection and quantification using the same is also disclosed.
    Type: Grant
    Filed: December 29, 2008
    Date of Patent: April 10, 2012
    Assignee: Purdue Research Foundation
    Inventors: Vincent Jo Davisson, Shirshendu K. Deb, Giselle Marcelline Knudsen-Mooney, Meiguo Xin
  • Patent number: 8153680
    Abstract: Compounds and methods for treating cancer or inducing apoptosis in proliferating cells. The compounds are shown in formula I: wherein X is selected from hydroxyl, thiol, and amino; Y is selected from carboxyl and sulfonyl; R1, R2, R3, and R4 are selected from hydrogen, lower alkyl, and combinations thereof; R5, R6, and R7 are selected from hydrogen, halo, nitro, amino, methoxy, and combinations thereof; and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: August 25, 2009
    Date of Patent: April 10, 2012
    Assignee: The Ohio State University Research Foundation
    Inventors: Ching-Shih Chen, Jing-Ru Weng
  • Patent number: 8153378
    Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.
    Type: Grant
    Filed: January 29, 2010
    Date of Patent: April 10, 2012
    Assignees: Genomic Health, Inc., NSABP Foundations, Inc.
    Inventors: Wayne Cowens, Joffre B. Baker, Kim Clark, James Hackett, Drew Watson, Soonmyung Paik
  • Publication number: 20120080678
    Abstract: Exemplary embodiments provide compositions for a solution process, electronic devices fabricated using the same, and fabrication methods thereof An oxide nano-structure is formed using a sol-gel process. An oxide thin film transistor is formed using the oxide nano-structure.
    Type: Application
    Filed: May 24, 2010
    Publication date: April 5, 2012
    Applicant: Industry-Academic Cooperation Foundation, Yonsei University
    Inventors: Hyun Jae Kim, Woong Hee Jeong, Byung Du Ahn, Gun Hee Kim
  • Publication number: 20120079764
    Abstract: The present disclosure describes methods and compositions for reducing turf thatch and/or preventing turf thatch buildup.
    Type: Application
    Filed: September 30, 2011
    Publication date: April 5, 2012
    Applicant: University of Georgia Research Foundation, Inc.
    Inventors: Qingguo Huang, Sudeep S. Sidhu, Paul L. Raymer, Robert N. Carrow
  • Publication number: 20120081668
    Abstract: Macular pigments are measured by spectrally selective lipofuscin detection. Light from a light source that emits light at a selected range of wavelengths that overlap the absorption band of macular carotenoids is directed onto macular tissue of an eye for which macular pigment levels are to be measured. Emitted light is then collected from the macular tissue. The collected light is filtered so that the collected light includes lipofuscin emission from the macular tissue at an excitation wavelength that lies outside the macular pigment absorption range and outside the excitation range of interfering fluorophores. The collected light is quantified at each of a plurality of locations in the macular tissue and the macular pigment levels in the macular tissue are determined from the differing lipofuscin emission intensities in the macula and peripheral retina.
    Type: Application
    Filed: December 9, 2011
    Publication date: April 5, 2012
    Applicant: The University of Utah Research Foundation
    Inventors: Werner Gellerman, Mohsen Sharifzadeh
  • Publication number: 20120083687
    Abstract: Systems and methods which generate a sequence of images using turbo spin echo magnetic resonance imaging which are retrospectively correlated with periodic motion occurring within a subject being imaged are described. In one embodiment, k-space measurements (or the measurements from which images are formed) are captured during, and correlated with, different phases in a cardiac cycle of the subject. With this sequence, the images that are produced are able to show, and/or compensate for, motion correlated with the cardiac cycle of the subject.
    Type: Application
    Filed: September 30, 2010
    Publication date: April 5, 2012
    Applicant: University of Utah Research Foundation
    Inventors: Dennis L. Parker, Jason K. Mendes, Jordan Hulet
  • Publication number: 20120082676
    Abstract: One aspect of the present invention provides a method of treating or preventing angioedema in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent that is capable of inhibiting the interaction of HK with gC1q-R. One aspect of the present invention provides a method of treating or preventing vascular permeability in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent that is capable of inhibiting the interaction of HK with gC1q-R.
    Type: Application
    Filed: March 29, 2010
    Publication date: April 5, 2012
    Applicant: The Research Foundation of State University of New York
    Inventor: Berhane Ghebrehiwet
  • Publication number: 20120083002
    Abstract: The present invention relates to a composition for modulating the activation of Nurr1, the composition comprising an agonist or an antagonist of a dopamine D2 receptor, methods for modulating the activation of Nurr1 by the dopamine D2 receptor, a method and composition for treating Nurr1-related diseases using the dopamine D2 receptor, and methods for screening a modulator of a dopamine D2 receptor of a test compound. Accordingly, the activation of Nurr1 can be modulated by treating the dopaminergic neurons with the agonist or the antagonist of the dopamine D2 receptor, thereby enhancing or inhibiting generation of the dopaminergic neurons.
    Type: Application
    Filed: October 12, 2011
    Publication date: April 5, 2012
    Applicant: Korea University Industry And Academy Cooperation Foundation
    Inventors: Ja hyun BAIK, Sung yul KIM
  • Publication number: 20120082351
    Abstract: Fast and continuous registration between two imaging modalities makes it possible to completely determine the rigid transformation between multiple sources at real-time or near real-time frame-rates in order to localize video cameras and register the two sources. A set of reference images are computed or captured within a known environment, with corresponding depth maps and image gradients defining a reference source. Given one frame from a real-time or near-real time video feed, and starting from an initial guess of viewpoint, a real-time video frame is warped to the nearest viewing site of the reference source. An image difference is computed between the warped video frame and the reference image. Steps are repeated for each frame until the viewpoint converges or the next video frame becomes available. The final viewpoint gives an estimate of the relative rotation and translation between the camera at that particular video frame and the reference source.
    Type: Application
    Filed: November 16, 2011
    Publication date: April 5, 2012
    Applicant: The Penn State Research Foundation
    Inventors: William E. Higgins, Scott A. Merritt, Lav Rai
  • Publication number: 20120083989
    Abstract: A combustion phase detection method is able to reduce exhaust gas and to improve combustion stability, to compensate injection and ignition delay time between combustion chambers and between cycles, and to detect a combustion phase in real time such that a heat generation rate and a heat release can be effectively calculated at an early state of the combustion by using a combustion pressure and a motoring pressure difference of an engine not affected by an offset value of the cylinder pressure. The combustion phase detection method of an engine may include detecting a combustion phase according to fuel injection timing by using a specific point of DHdP that is calculated by the following heat release equation: DHdP:?1/??1VdPdiff/d?d?. Here, Pdiff is a difference (Pdiff=P?Pmotoring) between a cylinder measure combustion pressure (P) and a motoring pressure (Pmotoring).
    Type: Application
    Filed: September 19, 2011
    Publication date: April 5, 2012
    Applicants: IUCF-HYU (Industry-University Cooperation Foundation Hanyang University), Hyundai Motor Company
    Inventors: Kyoungchan Han, Sunghwan Cho, Myoungho Sunwoo, Seungsuk Oh, Jongsuk Lim, Jaesung Chung, Kangyoon Lee
  • Publication number: 20120084068
    Abstract: A computing device simulates a test system by defining parameter values to be used to populate certain modeling formulas defining the test system. The defined parameter values correspond to one of the many points defining a domain in which the test system is to be simulated. The simulation iteratively solves the modeling formulas for each unit of the test system model space for each point in the domain in which the test system is simulated. Results for the subjects of interest are calculated at each iteration using the populated modeling formulas. A variance of the subjects of interest is also calculated at each iteration using a correlation coefficient obtained for the subjects of interest. The iterations of defining the parameter values and calculating the value and variance of the subjects of interest in the test system model space continues until all points in the domain have been simulated.
    Type: Application
    Filed: September 30, 2010
    Publication date: April 5, 2012
    Applicant: University of Utah Research Foundation
    Inventors: Steven M. Smith, Cynthia Furse
  • Publication number: 20120080313
    Abstract: Electroosmotic (EO) devices are provided which are not subject to mechanical wear and tear and with no moving parts, and having improved flow rates and electrical properties. Atomic layer deposition can be used to prepare three electrical terminal active zeta potential modulated EO devices from porous membranes. First, second, and further thin layers of materials can be formed with the pores. Thus, embedded electrodes can be formed along the length of the pores. The zeta potential in the pores can be modified by use of a voltage potential applied the embedded electrode, thereby achieving active control of surface zeta potential within the pores and active control of flow through the pores.
    Type: Application
    Filed: October 24, 2011
    Publication date: April 5, 2012
    Applicant: Old Dominion University Research Foundation
    Inventors: Helmut BAUMGART, Diefeng Gu, Tarek Abdel-Fattah, Ali Beskok, Seungkyung Park
  • Publication number: 20120082877
    Abstract: A cathode, a method of forming the cathode and a lithium battery including the cathode. The cathode includes a current collector and a cathode active material layer disposed on the current collector; the cathode active material layer includes a lithium transition metal oxide having a spinel structure, a conductive agent, and a binder; and at least a portion of a surface of the cathode active material layer is fluorinated.
    Type: Application
    Filed: August 3, 2011
    Publication date: April 5, 2012
    Applicants: Industry-University Cooperation Foundation Hanyang University, Samsung Electronics Co., Ltd.
    Inventors: Min-sang SONG, Han-su Kim, Jae-man Choi, Moon-seok Kwon, Un-gyu Paik, Tae-seup Song
  • Publication number: 20120083465
    Abstract: A method and medicament is provided for treating and inhibiting interaction of the receptor for advanced glycation end-products (RAGE) and its ligands using a natural or synthetic sulfated polysaccharide, preferably a 2-O desulfated heparin. The medicament preferably is administered intravenously, by aerosolization, intra-nasally, intra-articularly, intra-thecally, subcutaneously, topically or orally. The medicament is useful for treating a variety of conditions, including diabetes, inflammation, renal failure, aging, systemic amyloidosis, Alzheimer's disease, inflammatory arthritis, atherosclerosis, and colitis.
    Type: Application
    Filed: April 1, 2011
    Publication date: April 5, 2012
    Applicant: University of Utah Research Foundation
    Inventor: Thomas P. Kennedy
  • Publication number: 20120084884
    Abstract: Methods that provide for stable transformation of fern spores and/or protonemata by Agrobacterium- and/or by particle-mediated transformation are disclosed. Also provided are stably transformed, non-chimeric ferns.
    Type: Application
    Filed: October 5, 2011
    Publication date: April 5, 2012
    Applicant: University of Tennessee Research Foundation
    Inventors: Neal Stewart, Muthukumar Balasubramaniam, Blake Joyce
  • Publication number: 20120082355
    Abstract: A self-navigating technique designed to detect motion in segmented sequences is disclosed. Certain embodiments compare a plurality of segments containing adjacent sets of k-space lines and produce an aliased error function which corresponds to a correlation of the segments. A global shift of the aliased error function may indicate the presence of in-plane rigid-body translation while other types of motion are evident in the dispersion or breadth of the error function. Some embodiments may then replace motion corrupted data with reacquired data. Further, some embodiments may correct or remove corrupted data retrospectively.
    Type: Application
    Filed: September 30, 2010
    Publication date: April 5, 2012
    Applicant: University of Utah Research Foundation
    Inventors: Jason K. Mendes, Dennis L. Parker
  • Publication number: 20120083992
    Abstract: A combustion phase detection method of an engine has the advantages of being able to reduce exhaust gas and to improve combustion stability, to compensate injection and ignition delay time between combustion chambers and between cycles, and to detect a combustion phase in real time such that a heat generation rate and heat release can be effectively calculated in an early state of combustion with a simple calculation method to control combustion of an engine, by using a combustion pressure and a motoring pressure difference of an engine not affected by an offset value of the cylinder pressure. For this, a combustion phase detection method may include detecting a combustion phase by using a specific point of DRdV as follows: DR ? ? V ? : ? ? P diff ? ? V ? ? max ( P diff ? ? V ? ? ) Here, the Pdiff (P-Pmotoring) is a difference between a cylinder measure combust pressure (P) and a motoring pressure (Pmotoring), and V is a combustion chamber volume.
    Type: Application
    Filed: September 21, 2011
    Publication date: April 5, 2012
    Applicants: IUCF-HYU (Industry-University Cooperation Foundation Hanyang University), Hyundai Motor Company
    Inventors: Kyoungchan HAN, Sunghwan CHO, Myoungho SUNWOO, Seungsuk OH, Jongsuk LIM, Jaesung CHUNG, Kangyoon LEE
  • Patent number: 8147823
    Abstract: A method for treating an ocular disorder characterized by the defect or absence of a normal gene in the ocular cells of a human or animal subject involves administering to the subject by subretinal injection an effective amount of a recombinant adeno-associated virus carrying a nucleic acid sequence encoding the normal gene under the control of a promoter sequence which expresses the product of the gene in the ocular cells. The ocular cells are preferably retinal pigment epithelial (RPE) cells, and the gene is preferably an RPE-specific gene, e.g., RPE65. The promoter is one that can express the gene product in the RPE cells. Compositions for subretinal administration are useful in this method.
    Type: Grant
    Filed: July 8, 2010
    Date of Patent: April 3, 2012
    Assignees: The Trustees of the University of Pennsylvania, University of Florida Research Foundation, Incorporated, Cornell Research Foundation Inc.
    Inventors: Gregory M. Acland, Gustavo D. Aguirre, Jean Bennett, William W. Hauswirth, Samuel G. Jacobson, Albert M. Maguire